ARTICLE | Company News
Weill Cornell Medical College, Angiocrine Bioscience deal
September 22, 2014 7:00 AM UTC
Angiocrine licensed rights from the college to technology that converts patient's own endothelial cells into hematopoietic stem cells. Angiocrine will use the technology to produce hematopoietic cell ...